Aethlon Medical (AEMD) Long-Term Deferred Tax (2015 - 2025)

Aethlon Medical (AEMD) has 11 years of Long-Term Deferred Tax data on file, last reported at $34.4 million in Q1 2025.

• For the quarter ending Q1 2025, Long-Term Deferred Tax rose 3.42% year-over-year to $34.4 million; the trailing twelve-month figure through Mar 2025 stood at $34.4 million (up 3.42% YoY), and the FY2025 full-year result was $34.4 million, up 3.42% from the prior year.
• Long-Term Deferred Tax for Q1 2025 stood at $34.4 million, up from $33.3 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $34.4 million in Q1 2025 and bottomed at $24.8 million in Q1 2021.
• The 5-year median for Long-Term Deferred Tax is $30.0 million (2023), against an average of $29.9 million.
• The widest annual swing landed in 2023, when Long-Term Deferred Tax rose 10.82%; it then climbed 3.42% in 2025.
• A 5-year view of Long-Term Deferred Tax shows it stood at $24.8 million in 2021, then grew by 9.4% to $27.1 million in 2022, then climbed by 10.82% to $30.0 million in 2023, then climbed by 10.78% to $33.3 million in 2024, then grew by 3.42% to $34.4 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $34.4 million (Q1 2025), $33.3 million (Q1 2024), and $30.0 million (Q1 2023), per Business Quant data.

Peer Comparison